Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renata Kellnerova(5.5%),PPF GROUP N.V.(5.5%), etc.
Autolus Therapeutics | D: Filing D
Autolus Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-BioNTech SE(12.5%)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(2.21%),Steven Boyd(2.21%)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.82%),Deep Track Biotechnology Master Fund, Ltd.(6.82%), etc.
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tetragon Financial Group Limited(4.6%),Tetragon Financial Management L.P.(4.6%), etc.
Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals
Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Tetragon Financial Group Limited(5.5%),Tetragon Financial Management L.P.(5.5%), etc.
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(4.7%),Wilmot B. Harkey(4.7%), etc.
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(2.2%),Patrick J. Heron(2.2%), etc.
Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(5.91%),Steven Boyd(5.91%)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(8.67%),Deep Track Biotechnology Master Fund, Ltd.(8.67%), etc.
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital World Investors(0.4%)
Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.03%),Deep Track Biotechnology Master Fund, Ltd.(9.03%), etc.
Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BXLS V – Autobahn L.P.(14.0%),Blackstone Life Sciences Associates V (CYM) L.L.C.(14.0%), etc.
Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Qatar Investment Authority(9.03%)
Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renata Kellnerova(16.1%),PPF GROUP N.V.(16.1%), etc.
No Data